{"id":49259,"date":"2024-11-11T11:11:12","date_gmt":"2024-11-11T11:11:12","guid":{"rendered":"https:\/\/www.elza-institute.com\/?p=44839"},"modified":"2024-11-11T11:11:12","modified_gmt":"2024-11-11T11:11:12","slug":"keratoconus-treatment-cross-linking","status":"publish","type":"post","link":"https:\/\/www.elza-institute.com\/pt\/keratoconus-treatment-cross-linking\/","title":{"rendered":"ELZA na revista Nature Reviews Disease Primers"},"content":{"rendered":"<article>Numa publica\u00e7\u00e3o importante, <em>Revis\u00f5es da Natureza Cartilhas sobre doen\u00e7as<\/em> (fator de impacto=76,9) forneceu um <a href=\"https:\/\/doi.org\/10.1038\/s41572-024-00565-3\">vis\u00e3o geral pormenorizada do tratamento do ceratocone<\/a> e os v\u00e1rios factores que determinam esta complexa doen\u00e7a ocular. Esta an\u00e1lise de especialistas respeitados, incluindo o Diretor M\u00e9dico do ELZA, <a href=\"https:\/\/www.elza-institute.com\/pt\/sobre\/farhad-hafezi\/\">Farhad Hafezi, MD, PhD, FARVO<\/a>O livro, que \u00e9 uma publica\u00e7\u00e3o de refer\u00eancia, destaca os mais recentes conhecimentos sobre as causas do ceratocone, os avan\u00e7os no diagn\u00f3stico e a evolu\u00e7\u00e3o dos tratamentos.<\/p>\n<h3>A complexidade do ceratocone e a sua etiologia<\/h3>\n<p><strong>Ceratocone<\/strong> O ceratocone afecta principalmente adolescentes e adultos jovens, caracterizando-se por um enfraquecimento progressivo da c\u00f3rnea que resulta num adelga\u00e7amento da c\u00f3rnea e numa inclina\u00e7\u00e3o semelhante a um cone, o que leva a um astigmatismo irregular crescente e a uma diminui\u00e7\u00e3o da vis\u00e3o. A revis\u00e3o destaca a etiologia complexa subjacente ao ceratocone, incluindo factores gen\u00e9ticos, ambientais, biomec\u00e2nicos e celulares. O artigo salienta a forma como as influ\u00eancias ambientais, como a fric\u00e7\u00e3o dos olhos e a exposi\u00e7\u00e3o \u00e0 luz UV, est\u00e3o associadas \u00e0 progress\u00e3o da doen\u00e7a e real\u00e7a a import\u00e2ncia de as pessoas n\u00e3o esfregarem os olhos.<\/p>\n<h3>Mecanismos celulares e o seu papel no ceratocone<\/h3>\n<p>A n\u00edvel celular, o ceratocone envolve perturba\u00e7\u00f5es nas vias bioqu\u00edmicas que afectam os processos end\u00f3genos de liga\u00e7\u00e3o cruzada do colag\u00e9nio no estroma da c\u00f3rnea, levando \u00e0 distor\u00e7\u00e3o da estrutura da c\u00f3rnea. As altera\u00e7\u00f5es hormonais podem agravar ainda mais a instabilidade estrutural.<\/p>\n<h3>Diagn\u00f3stico e monitoriza\u00e7\u00e3o atrav\u00e9s de imagiologia avan\u00e7ada<\/h3>\n<p>O diagn\u00f3stico cl\u00ednico do ceratocone melhorou com a introdu\u00e7\u00e3o de tecnologias avan\u00e7adas de imagiologia, como o disco de Pl\u00e1cido e os top\u00f3grafos e tom\u00f3grafos corneanos baseados em OCT. Estas ferramentas permitem a dete\u00e7\u00e3o precoce e a monitoriza\u00e7\u00e3o mais precisa da progress\u00e3o da doen\u00e7a e ajudam os m\u00e9dicos a personalizar os planos de tratamento do ceratocone com base na gravidade da doen\u00e7a e na taxa de progress\u00e3o.<\/p>\n<h3>Op\u00e7\u00f5es de tratamento personalizadas para o ceratocone<\/h3>\n<p>As estrat\u00e9gias de tratamento variam consoante a fase da doen\u00e7a. No in\u00edcio do ceratocone, os \u00f3culos ou as lentes de contacto moles podem corrigir a vis\u00e3o. \u00c0 medida que o ceratocone progride, os doentes necessitam frequentemente de lentes r\u00edgidas perme\u00e1veis ao g\u00e1s ou lentes esclerais para melhorar a acuidade visual. O avan\u00e7o mais significativo no tratamento do ceratocone nas \u00faltimas duas d\u00e9cadas foi a introdu\u00e7\u00e3o do cross-linking corneano (CXL), que aumenta a resist\u00eancia da c\u00f3rnea, estabilizando a forma da c\u00f3rnea e prevenindo novas ectasias.<\/p>\n<p>Para casos avan\u00e7ados com cicatrizes na c\u00f3rnea ou quando as lentes de contacto s\u00e3o intoler\u00e1veis, tornam-se necess\u00e1rias interven\u00e7\u00f5es cir\u00fargicas. Estas op\u00e7\u00f5es cir\u00fargicas constituem uma \u00faltima linha de defesa na recupera\u00e7\u00e3o da vis\u00e3o de indiv\u00edduos gravemente afectados pelo ceratocone.<\/p>\n<p>A an\u00e1lise, publicada na prestigiada revista <em>Revis\u00f5es da Natureza Cartilhas sobre doen\u00e7as<\/em>O artigo, publicado na revista \"The New York Times\", reflecte o reconhecimento da medicina de que o ceratocone \u00e9 uma doen\u00e7a importante, complexa e multidimensional. O artigo est\u00e1 dispon\u00edvel para leitura <a href=\"https:\/\/doi.org\/10.1038\/s41572-024-00565-3\">aqui<\/a>.<\/p>\n<\/article>\n<p><a href=\"https:\/\/doi.org\/10.1038\/s41572-024-00565-3\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-44844 size-full\" src=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/11\/nature-reviews-primer-keratoconus.jpg\" alt=\"\" width=\"681\" height=\"467\" \/><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Explorando o tratamento completo do ceratocone, desde o cross-linking \u00e0 cirurgia, na conceituada revista cient\u00edfica Nature Reviews.<\/p>","protected":false},"author":4,"featured_media":49182,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[214,95],"tags":[779,209,132,778,125,105,116,130,100,945,758,831,123,624,104,122],"class_list":["post-49259","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-farhad-hafezi","category-scientific-article","tag-all-femto-cairs","tag-basic-research","tag-biomechanics","tag-cairs","tag-cornea","tag-corneal-infection","tag-corneal-ulcer","tag-cross-linking","tag-cxl","tag-elza-pace","tag-femto-cairs","tag-femtocairs","tag-keratoconus","tag-pace","tag-pack-cxl","tag-translational-research"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ELZA in Nature Reviews Disease Primers - The ELZA Institute<\/title>\n<meta name=\"description\" content=\"ELZA is involved in a Nature Reviews paper that describes the latest in keratoconus treatment, including CXL and other advanced surgeries.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elza-institute.com\/pt\/keratoconus-treatment-cross-linking\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ELZA in Nature Reviews Disease Primers - The ELZA Institute\" \/>\n<meta property=\"og:description\" content=\"ELZA is involved in a Nature Reviews paper that describes the latest in keratoconus treatment, including CXL and other advanced surgeries.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elza-institute.com\/pt\/keratoconus-treatment-cross-linking\/\" \/>\n<meta property=\"og:site_name\" content=\"The ELZA Institute\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ELZA.Institute\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-11T11:11:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/11\/featured-image-nature-reviews-primer-keratoconus.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mark Hillen\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark Hillen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/\"},\"author\":{\"name\":\"Mark Hillen\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15\"},\"headline\":\"ELZA in Nature Reviews Disease Primers\",\"datePublished\":\"2024-11-11T11:11:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/\"},\"wordCount\":383,\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/11\/featured-image-nature-reviews-primer-keratoconus.jpg\",\"keywords\":[\"all femto cairs\",\"Basic Research\",\"Biomechanics\",\"cairs\",\"Cornea\",\"Corneal infection\",\"Corneal ulcer\",\"Cross-Linking\",\"CXL\",\"elza-pace\",\"femto-cairs\",\"femtocairs\",\"Keratoconus\",\"pace\",\"PACK-CXL\",\"Translational Research\"],\"articleSection\":[\"Farhad Hafezi\",\"Scientific article\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/\",\"url\":\"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/\",\"name\":\"ELZA in Nature Reviews Disease Primers - The ELZA Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/11\/featured-image-nature-reviews-primer-keratoconus.jpg\",\"datePublished\":\"2024-11-11T11:11:12+00:00\",\"description\":\"ELZA is involved in a Nature Reviews paper that describes the latest in keratoconus treatment, including CXL and other advanced surgeries.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#primaryimage\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/11\/featured-image-nature-reviews-primer-keratoconus.jpg\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/11\/featured-image-nature-reviews-primer-keratoconus.jpg\",\"width\":1200,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.elza-institute.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farhad Hafezi\",\"item\":\"https:\/\/www.elza-institute.com\/farhad-hafezi\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ELZA in Nature Reviews Disease Primers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.elza-institute.com\/#website\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"name\":\"The ELZA Institute\",\"description\":\"Swiss EyeCare at its finest\",\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.elza-institute.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.elza-institute.com\/#organization\",\"name\":\"The ELZA Institute\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"width\":1181,\"height\":453,\"caption\":\"The ELZA Institute\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ELZA.Institute\/\",\"https:\/\/x.com\/ELZA_Institute\",\"https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15\",\"name\":\"Mark Hillen\",\"url\":\"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ELZA na Nature Reviews Disease Primers - O Instituto ELZA","description":"A ELZA est\u00e1 envolvida num artigo da Nature Reviews que descreve as \u00faltimas novidades no tratamento do ceratocone, incluindo o CXL e outras cirurgias avan\u00e7adas.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elza-institute.com\/pt\/keratoconus-treatment-cross-linking\/","og_locale":"pt_PT","og_type":"article","og_title":"ELZA in Nature Reviews Disease Primers - The ELZA Institute","og_description":"ELZA is involved in a Nature Reviews paper that describes the latest in keratoconus treatment, including CXL and other advanced surgeries.","og_url":"https:\/\/www.elza-institute.com\/pt\/keratoconus-treatment-cross-linking\/","og_site_name":"The ELZA Institute","article_publisher":"https:\/\/www.facebook.com\/ELZA.Institute\/","article_published_time":"2024-11-11T11:11:12+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/11\/featured-image-nature-reviews-primer-keratoconus.jpg","type":"image\/jpeg"}],"author":"Mark Hillen","twitter_misc":{"Escrito por":"Mark Hillen","Tempo estimado de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#article","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/"},"author":{"name":"Mark Hillen","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15"},"headline":"ELZA in Nature Reviews Disease Primers","datePublished":"2024-11-11T11:11:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/"},"wordCount":383,"publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"image":{"@id":"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/11\/featured-image-nature-reviews-primer-keratoconus.jpg","keywords":["all femto cairs","Basic Research","Biomechanics","cairs","Cornea","Corneal infection","Corneal ulcer","Cross-Linking","CXL","elza-pace","femto-cairs","femtocairs","Keratoconus","pace","PACK-CXL","Translational Research"],"articleSection":["Farhad Hafezi","Scientific article"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/","url":"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/","name":"ELZA na Nature Reviews Disease Primers - O Instituto ELZA","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#primaryimage"},"image":{"@id":"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/11\/featured-image-nature-reviews-primer-keratoconus.jpg","datePublished":"2024-11-11T11:11:12+00:00","description":"A ELZA est\u00e1 envolvida num artigo da Nature Reviews que descreve as \u00faltimas novidades no tratamento do ceratocone, incluindo o CXL e outras cirurgias avan\u00e7adas.","breadcrumb":{"@id":"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#primaryimage","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/11\/featured-image-nature-reviews-primer-keratoconus.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/11\/featured-image-nature-reviews-primer-keratoconus.jpg","width":1200,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.elza-institute.com\/keratoconus-treatment-cross-linking\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elza-institute.com\/"},{"@type":"ListItem","position":2,"name":"Farhad Hafezi","item":"https:\/\/www.elza-institute.com\/farhad-hafezi\/"},{"@type":"ListItem","position":3,"name":"ELZA in Nature Reviews Disease Primers"}]},{"@type":"WebSite","@id":"https:\/\/www.elza-institute.com\/#website","url":"https:\/\/www.elza-institute.com\/","name":"O Instituto ELZA","description":"Swiss EyeCare no seu melhor","publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elza-institute.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/www.elza-institute.com\/#organization","name":"O Instituto ELZA","url":"https:\/\/www.elza-institute.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","width":1181,"height":453,"caption":"The ELZA Institute"},"image":{"@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ELZA.Institute\/","https:\/\/x.com\/ELZA_Institute","https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home"]},{"@type":"Person","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15","name":"Mark Hillen","url":"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/49259","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/comments?post=49259"}],"version-history":[{"count":0,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/49259\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media\/49182"}],"wp:attachment":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media?parent=49259"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/categories?post=49259"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/tags?post=49259"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}